Headline News

According to published results, the use of gabapentinoids may be associated with an increased risk of hip fractures in older, frail patients and patients with chronic kidney disease.

The European Commission has approved Opuviz 40 mg/mL solution, a biosimilar referencing Eylea, according to a press release from Samsung Bioepis and Biogen.

BOSTON — Physicians should make technology work for them and not be afraid of it, Priya Bansal, MD, said during her presentation on optimizing workflow at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

For individuals with ALS, a daily dosing regimen of oral edaravone was nonsuperior to an FDA-approved staggered regimen of the drug plus placebo, according to a poster presented at AANEM.

INDIANAPOLIS — Although early detection of keratoconus is critical, it is also important to understand how to manage later-onset or progressive disease in older patients, according to a lecture at Academy 2024.

Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet dispenser is not meeting its primary endpoint of a less than 0.50 D progression in visual acuity over 3 years, according to a press release.

The WikiGuidelines collaborative has published the first guidelines for UTI prevention, diagnosis and management in more than a decade.

NEW YORK — As vaccination coverage declines globally, pediatricians need to prepare to encounter more measles cases in their communities, according to a presentation at the Infectious Diseases in Children Symposium.

Older women with chronic kidney disease who take denosumab may have a higher risk for emergently treated hypocalcemia compared with those treated with bisphosphonates, according to published data.

WASHINGTON — Among patients with systemic autoimmune rheumatic diseases, circulating interleukin-18 levels were lower in those with long COVID vs. those without, according to data presented at ACR Convergence 2024.